Characterization of a Bovine Serum Albumin‐Derived Pro‐Cognitive Peptide ( bSAPP ): An Orally Active Peptide Alleviates Cognitive Decline in HFD ‐Fed Mice via CCK Signaling Through the Gut‐Brain Axis
Authors:
Open Access
- 17 December 2025
- journal article
- Published by Wiley in The FASEB Journal
- Vol. 39 (24) , e71366
Abstract
The global prevalence and burden of dementia continue to rise, driven not only by an aging population but also by obesity associated with unhealthy dietary habits. From a Quality of Life (QoL) perspective, identifying naturally derived compounds that enhance cognitive function is increasingly encouraged alongside pharmaceutical interventions. In this study, we investigated the anti‐dementia effects of a peptide derived from bovine serum albumin using high‐fat diet (HFD)‐fed mice. We first found that the enzymatic digest of bovine serum albumin could orally alleviate cognitive decline induced by HFD. Then, we confirmed the oral pro‐cognitive effects of the peptide derived from the digest and the underlying mechanisms. The peptide had an EC 50 of 0.01 mg/kg BW/day. Therefore, we designated it bSAPP (bovine serum albumin‐derived pro‐cognitive peptide). The cognition‐enhancing effects of bSAPP were blunted by an α7nAChR antagonist, suggesting that the pro‐cognitive effect of bSAPP was mediated by acetylcholine signaling. Moreover, bSAPP became ineffective in the presence of a CCK1R antagonist as well as in CCK1R −/− mice, highlighting the involvement of CCK1R signaling. Furthermore, bSAPP increased the number of BrdU‐positive cells in the dentate gyrus of the hippocampus and upregulated hippocampal expression of VEGF and NGF in a CCK1R‐dependent manner. Additionally, the cognitive benefits of bSAPP were nullified by a capsaicin pre‐treatment. In summary, we observed that bSAPP could orally enhance cognitive function in HFD‐fed mice through CCK1R signaling via the gut‐brain axis, accompanied by facilitated hippocampal cell proliferation and involvement of acetylcholine signaling.Keywords
Funding Information
- Japan Society for the Promotion of Science (23K23553:25K01966)
This publication has 60 references indexed in Scilit:
- Extent and Direction of Ghrelin Transport Across the Blood-Brain Barrier Is Determined by Its Unique Primary StructureThe Journal of Pharmacology and Experimental Therapeutics, 2002
- Role of CCK-A Receptor for Pancreatic Function in Mice: A Study in CCK-A Receptor Knockout MicePancreas, 2002
- Impaired Learning and Memory in OLETF Rats Without Cholecystokinin (CCK)-A ReceptorPhysiology & Behavior, 1999
- Cholecystokinin-8 protects central cholinergic neurons against fimbria–fornix lesion through the up-regulation of nerve growth factor synthesisProceedings of the National Academy of Sciences, 1999
- Donepezil Improves Cognition and Global Function in Alzheimer DiseaseA 15-Week, Double-blind, Placebo-Controlled StudyArchives of internal medicine (1960), 1998
- Cholecystokinin‐8 regulation of NGF concentrations in adult mouse brain through a mechanism involving CCKA and CCKB receptorsBritish Journal of Pharmacology, 1998
- Peripheral administration of cholecystokinin activates c-fos expression in the locus coeruleus/subcoeruleus nucleus, dorsal vagal complex and paraventricular nucleus via capsaicin-sensitive vagal afferents and CCK-A receptors in the ratBrain Research, 1997
- Capsaicin-resistant vagal afferent fibers in the rat gastrointestinal tract: anatomical identification and functional integrityBrain Research, 1997
- Cholecystokinin Protects Cholinergic Neurons against Basal Forebrain LesionThe Japanese Journal of Pharmacology, 1992
- Nerve growth factor increases choline acetyltransferase activity in developing basal forebrain neuronsMolecular Brain Research, 1986